Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Chicago Rivet & Machine Co. (CVR)

26.95   -0.47 (-1.71%) 05-20 13:43
Open: 27.42 Pre. Close: 27.42
High: 27.42 Low: 26.515
Volume: 16,041 Market Cap: 26M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 27.45 - 27.674 27.674 - 27.824
Low: 26.051 - 26.295 26.295 - 26.459
Close: 26.627 - 27.009 27.009 - 27.265

Technical analysis

as of: 2019-05-20 4:26:21 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 33.09     One year: 34.44
Support: Support1: 26.46    Support2: 22.01
Resistance: Resistance1: 28.33    Resistance2: 29.49
Pivot: 28.18
Moving Average: MA(5): 27.58     MA(20): 28.21
MA(100): 28.97     MA(250): 30.69
MACD: MACD(12,26): -0.26     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 31.35     %D(3): 39.68
RSI: RSI(14): 34.89
52-week: High: 34.90  Low: 26.46  Change(%): -15.8
Average Vol(K): 3-Month: 207  10-Days: 585

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CVR has closed below the lower band by 5.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 0.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 19 Apr 2019 18:08:36 Z
5 Top Biotech Stocks to Buy in 2019

Tue, 16 Apr 2019 12:08:40 Z
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes

Wed, 03 Apr 2019 22:58:47 Z
Is Celgene Stock Still Worth Holding Onto in the Long Run?

Tue, 02 Apr 2019 22:59:39 Z
Why Celgene's Shares Soared 13.5% in March

Fri, 15 Mar 2019 19:07:53 Z
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Industrials
Industry:  Tools Accessories
Shares Out. (M) 0.97
Shares Float (M) 0.96
% Held by Insiders
% Held by Institutions 30.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 0.910
PEG Ratio
Profit Margin 4.41
Operating Margin 5.15
Return on Assets (ttm) 5.1
Return on Equity (ttm) 5.6
Qtrly Rev. Growth -13.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -59.50
Operating Cash Flow (M) 0.99
Levered Free Cash Flow (M) -2.30

Stock Valuations

P/E
P/E Growth Ratio
P/BV 29.62
P/S 702948.25
P/CF 26.41

Dividends & Splits

Dividend 3.209
Dividend Yield 0.12
Dividend Pay Date 2019-03-20
Ex-Dividend Date 2019-06-04
Forward Dividend 0.880
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.